Skip to main content
Better together.
Fred Hutch
Seattle Children's
UW Medicine
Enter the terms you wish to search for.

Related Nav

  • Contact Us
  • Donate and Volunteer
  • For Healthcare Professionals

Main navigation

  • New Patients
    • Why Seek Treatment at SCCA?
    • Preparing for Your First Visit
    • Locations
    • Transportation
    • Insurance Coverage and Bills
    • Services and Support
    • Patient Stories
  • Diseases and Treatments
    • Treatment Options
    • Clinical Trials
    • During Your Treatment
    • Coping with Side Effects
    • Palliative Care
    • Self Care
  • After Treatment
    • Coping with After Effects
    • Survivorship Events
  • Resources
    • Resources for Caregivers
    • For Children and Teens
    • Emotional and Spiritual Support
    • Health and Nutrition
    • Services and Support
    • Medical Record Request
Resources for Patients and Caregiviers
Your support team includes nutritionists, emotional support, caregiver resources, and so much more.
Learn more
Real Stories from Real Patients
Our patients share their stories of hope, care and outcomes
Learn more
Help Us Help Future Patients
Our patient advisory board helps us continually improve the patient experience. Join us.
Learn more
Caresi
Patient care app
Caresi® is a personal health app, created by SCCA for you, our patient. With the app, view your schedule, access lab results, contact care teams and review resources.
Learn more

Disease Information

  • Leukemia Overview
  • Leukemia Facts
    • Symptoms & Diagnosis
    • Definitions
  • Treatment Options
    • Chemotherapy
    • Radiation Treatment
    • New Treatments
    • Complementary and Integrative Medicine
  • Our Doctors
  • Our Expertise
  • What to Expect
    • Talking With Your Child About Cancer
    • Questions to Ask Your Child’s Doctor
  • Web Resources

Treatment Options

More than 85 percent of children with acute lymphocytic leukemia (ALL) survive at least five years after their cancer is diagnosed, and many live much longer. The cure rate for ALL ranges from about 60 percent to 95 percent depending on factors such as the type of the leukemia, the extent at the time of diagnosis and the child’s age.

About 40 percent to 50 percent of children with acute myelogenous leukemia (AML) are cured with standard chemotherapy. The rate is higher, at least 70 percent, for children who receive a bone marrow transplant from a brother or sister. As doctors find more successful treatments through clinical trials, the prognosis for children with leukemia will continue to improve.

The most common treatments for childhood leukemia are chemotherapy, radiation therapy, and bone marrow (hematopoietic stem cell) transplant, all of which are offered through Seattle Cancer Care Alliance (SCCA) and Seattle Children’s, an SCCA parent organization.

Bone Marrow Transplant

If your child or teen needs a bone marrow transplant, SCCA is the best place for this life-saving treatment. Fred Hutchinson Cancer Research Center pioneered the use of bone marrow transplantation to treat leukemia more than 40 years ago. The Fred Hutchinson Transplant Program at SCCA was ranked first in outcomes in a multi-year study conducted by the National Marrow Donor Program that measured one-year survival rates of patients at 122 transplant centers in the United States.1 

Phases of Treatment

Your child’s doctor and healthcare team will recommend a treatment plan for your child based on the type of leukemia your child has, your child’s age and other aspects of your child’s health.

Typically, children with leukemia go through three phases of treatment:

  • The first phase is called the induction phase. Treatment during this phase is designed to kill the leukemic cells in the blood and the bone marrow, putting the disease in remission. Children with either ALL or AML go through an induction phase. For most children with ALL, this phase takes about one month of treatment. For those with AML, induction usually takes a few months.
  • The second phase is called the consolidation/intensification phase. Treatment during this phase is designed to kill remaining leukemic cells that may be inactive but could begin growing again and cause the leukemia to recur. Children with either ALL or AML go through a consolidation/intensification phase, which usually lasts several months.
  • The third phase is called the maintenance phase. During this phase, treatment is continued to kill any remaining cells that could cause a recurrence, but often at lower doses. Children with ALL go through maintenance treatment, usually for two to three years. This phase does not apply to AML because research has found it is not effective.

Acute Lymphocytic Leukemia

Standard treatment for ALL is combination chemotherapy (using multiple drugs). Radiation therapy to the brain, spinal cord or testicles is sometimes used if the cancer has spread or there is a high risk that it may spread to those areas. Researchers are studying the use of bone marrow transplants in children with very high-risk and recurrent ALL, as well as new combinations of chemotherapy drugs. Seattle Children’s and SCCA participate in many research trials investigating new drugs and stem cell transplants.

Acute Myelogenous Leukemia

Standard treatment for AML is combination chemotherapy (using multiple drugs). Because AML is often more difficult to treat, doctors often consider giving a bone marrow transplant during a remission or for a recurrence of the disease. New treatments for AML are being researched, and doctors may recommend these treatments if your child’s AML comes back after the initial round of treatment.

Clinical Studies

Most children with leukemia or other types of cancer are treated through clinical studies. Read the section about participating in a study, which explains more about clinical studies and provides links to further information that may help you consider this option for your child.

More About Treatment Options

Locations
Request an Appointment
Find a Physician

Connect With Us

  • Contact Us
  • Request an Appointment
  • Careers
  • Referring Doctors
  • Phone Directory
  • Press and News
  • Social Media
  • Community Benefit
Follow Us
http://twitter.com/SeattleCCA
http://www.facebook.com/SeattleCancerCareAlliance
http://www.youtube.com/user/SeattleCancerCare
http://www.sccablog.org/
https://www.nccn.org/Members/Profiles/Default.aspx?MemberId=8
https://www.qualitycheck.org/quality-report/?bsnid=328340

SCCA Locations

  • South Lake Union
  • SCCA Issaquah
  • SCCA Peninsula
  • UW Medical Center
  • EvergreenHealth
  • UW Medicine’s Northwest Hospital
  • SCCA Proton Therapy Center
  • Seattle Children's

Seattle Cancer Care Alliance
825 Eastlake Ave. E
PO Box 19023
Seattle, WA 98109­-1023

 

 

 

 

Patient Educational Email Invitation Exposes Patient Information

©2004-2019 Seattle Cancer Care Alliance. All Rights Reserved.

footer legal links

  • SCCA Links
  • Privacy Policy
  • Public Care Policy
  • Disclaimer
  • Financial Assistance
  • Notice of Nondiscrimination

Seattle Cancer Care Alliance is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read EEO is the Law poster here. 

Better together.
Fred Hutch
Seattle Children's
UW Medicine